Clinical Trial Update: Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A trial comparing sequences of endocrine therapy and capecitabine in metastatic ER-positive breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: TERMINATED